BioSyntech, Inc.
BSYI · OTC
12/31/2009 | 9/30/2009 | 6/30/2009 | 3/31/2009 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,438 | $696 | $1,680 | $3,803 |
| Short-Term Investments | $0 | $0 | $0 | $1,132 |
| Receivables | $1,788 | $1,828 | $1,505 | $208 |
| Inventory | $32 | $32 | $62 | $57 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $3,676 | $2,825 | $3,470 | $5,357 |
| Property Plant & Equip (Net) | $1,595 | $1,668 | $1,750 | $1,840 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $13 | $609 | $3 | $3 |
| Total NC Assets | $1,608 | $2,277 | $1,753 | $1,843 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,284 | $5,101 | $5,223 | $7,199 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $497 |
| Short-Term Debt | $15,805 | $600 | $593 | $10,128 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $40 | $40 | $60 | $60 |
| Other Curr. Liab. | $1,450 | $2,937 | $843 | $0 |
| Total Curr. Liab. | $17,295 | $15,696 | $11,749 | $11,907 |
| LT Debt | $1,493 | $1,646 | $1,802 | $1,950 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1,493 | $1,646 | $1,802 | $1,950 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $12,120 | $10,253 | $0 |
| Total Liabilities | $18,788 | $17,343 | $13,551 | $13,858 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$76,993 | -$73,613 | -$69,463 | -$66,804 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $4,904 | $3,800 | $3,652 | $3,666 |
| Total Equity | -$13,504 | -$12,241 | -$8,328 | -$6,658 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,284 | $5,101 | $5,223 | $7,199 |
| Net Debt | $15,860 | $1,550 | $715 | $8,275 |